Manufacturer copay assistance · Rystiggo (J9333) · UCB
Eligible, commercially… · Maximum benefit Program maximum not stated on the page — call 1-844-599-2273 to confirm the current cap · Covers RYSTIGGO out-of-pocket costs; residents of MA, MN and RI are not eligible for copay support for administration costs
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
Rystiggo billing & access teams: these are the manufacturer's own published steps.
Published eligibility terms from the manufacturer. Exact eligibility is confirmed at enrollment.
Insurance accepted
Other requirements
Rystiggo (rozanolixizumab-noli) is billed under J9333 on the medical benefit when it's administered in a provider setting — that's the claim this copay card applies against.
This program excludes Medicare and Medicaid. If your patient has government insurance, a foundation disease fund is the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Rystiggo — the program's cap applies against the patient share CareCost calculates.
Yes — Savings on RYSTIGGO from UCB. Eligible, commercially insured patients may pay as little as $0 per dose. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible, commercially insured patients may pay as little as $0 per dose Maximum benefit: Program maximum not stated on the page — call 1-844-599-2273 to confirm the current cap. Covers RYSTIGGO out-of-pocket costs; residents of MA, MN and RI are not eligible for copay support for administration costs
Program maximum not stated on the page — call 1-844-599-2273 to confirm the current cap.
No — Savings on RYSTIGGO excludes medicare, medicaid, tricare, va, dod, government. Medicare/Medicaid patients should check the foundation disease funds covering Rystiggo instead (see “Other help for Rystiggo” below).